What is Oscar Health Inc (OSCR) stock price today?

Oscar Health Inc (OSCR) currently trades at $17.93 per share. The stock has a market capitalization of $5.40B and a P/E ratio of —x.

Is OSCR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Oscar Health Inc has a Smart Value Score of 42/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 0.96.

What is Oscar Health Inc's revenue and earnings?

Oscar Health Inc has trailing twelve-month (TTM) revenue of $11.70B with profit margins of -3.79%. Earnings per share (EPS) is $-1.69.

Is Oscar Health Inc financially healthy?

Oscar Health Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 0.96 places it in the distress.

OSCR

Oscar Health Inc

NYSE: OSCR · HEALTHCARE · HEALTHCARE PLANS

$17.93

-0.61% today

Updated 2026-04-29

Market cap

$5.40B

P/E ratio

—

P/S ratio

0.46x

EPS (TTM)

$-1.69

Dividend yield

—

52W range

$11 – $24

Volume

6.5M

Market cap

$5.40B

P/E ratio

—

P/S ratio

0.46x

EPS (TTM)

$-1.69

Dividend yield

—

52W range

$11 – $24

Volume

6.5M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

9.3

Growth

A+

4.0

Quality

2.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

1.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$16.10

-10.21%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy0 Buy5 Hold2 Sell1 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $662.84M — positive

+ Revenue growth 17.30% QoQ

+ Debt/equity 0.44x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z 0.96 — distress zone

- Thin margins at -3.79%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$4.13B	$5.86B	$9.18B	$11.70B	$11.70B
Net income	$-606.27M	$-270.73M	$25.43M	$-443.15M	$-352.61M
EPS	—	—	—	—	$-1.69
Free cash flow	$351.34M	$-297.74M	$950.30M	$1.06B	$662.84M
Profit margin	-14.70%	-4.62%	0.28%	-3.79%	-3.79%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
OSCR	$5.40B	42	9.3	2.0	5.0	4.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Oscar Health Inc trades at $17.93. Our Smart Value Score of 42/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.96, it sits in the distress. TTM revenue stands at $11.70B. with profit margins at -3.79%.

Frequently asked questions

What is Oscar Health Inc's stock price?

Oscar Health Inc (OSCR) trades at $17.93.

Is Oscar Health Inc overvalued?

Smart Value Score 42/100 (Grade D, Sell).

What is the price target of Oscar Health Inc (OSCR)?

The analyst target price is $16.10, representing -10.2% downside from the current price of $17.93.

What is Oscar Health Inc's revenue?

TTM revenue is $11.70B.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

0.96 — distress.

Company info

SectorHEALTHCARE

IndustryHEALTHCARE PLANS

CountryUSA

ExchangeNYSE

CurrencyUSD

www.hioscar.com

Quick metrics

P/S ratio0.46x

ROE-44.40%

Beta1.93

50D MA$13.95

200D MA$15.90

Shares out0.27B

Float0.24B

Short ratio—

Avg volume6.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

OSCR vs LLY →OSCR vs JNJ →OSCR vs ABBV →Stock screener →